Canadian Journal of Cardiology

Papers
(The H4-Index of Canadian Journal of Cardiology is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults344
Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children296
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation290
Missing Data in Clinical Research: A Tutorial on Multiple Imputation236
Opening the Black Box: The Promise and Limitations of Explainable Machine Learning in Cardiology168
Left Bundle Branch Pacing for Cardiac Resynchronization Therapy: Nonrandomized On-Treatment Comparison With His Bundle Pacing and Biventricular Pacing168
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction155
Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited142
Oxidative Stress: A Unifying Paradigm in Hypertension131
Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective125
Echocardiographic Findings in Patients With COVID-19 Pneumonia123
Management and Treatment of COVID-19: The Chinese Experience122
Inflammation in Hypertension117
Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance104
Cardiovascular Risk Factors and Prevention: A Perspective From Developing Countries93
Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society88
Direct Effects of Empagliflozin on Extracellular Matrix Remodelling in Human Cardiac Myofibroblasts: Novel Translational Clues to Explain EMPA-REG OUTCOME Results81
Characteristic Electrocardiographic Manifestations in Patients With COVID-1977
The Importance of Gender to Understand Sex Differences in Cardiovascular Disease73
Reduced Physical Activity During COVID-19 Pandemic in Children With Congenital Heart Disease73
Myocarditis After SARS-CoV-2 Vaccination: A Vaccine-Induced Reaction?66
Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis64
Cardiac Rehabilitation During the COVID-19 Era: Guidance on Implementing Virtual Care64
Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials59
The Global Effect of the COVID-19 Pandemic on STEMI Care: A Systematic Review and Meta-analysis58
COVID-19: A Time for Alternate Models in Cardiac Rehabilitation to Take Centre Stage51
Reduced Rate of Hospital Presentations for Heart Failure During the COVID-19 Pandemic in Toronto, Canada50
Sympathetic Nervous System Contributions to Hypertension: Updates and Therapeutic Relevance49
Precautions and Procedures for Coronary and Structural Cardiac Interventions During the COVID-19 Pandemic: Guidance from Canadian Association of Interventional Cardiology48
Management of Atrial Fibrillation in 2021: An Updated Comparison of the Current CCS/CHRS, ESC, and AHA/ACC/HRS Guidelines47
COVID-19–Myocarditis and Return to Play: Reflections and Recommendations From a Canadian Working Group47
Worsening Hypertension Awareness, Treatment, and Control Rates in Canadian Women Between 2007 and 201746
Simplifying Physiological Left Bundle Branch Area Pacing Using a New Nine-Partition Method45
Cardiac Surgery in Canada During the COVID-19 Pandemic: A Guidance Statement From the Canadian Society of Cardiac Surgeons45
How Structure, Mechanics, and Function of the Vasculature Contribute to Blood Pressure Elevation in Hypertension44
WHO HEARTS: A Global Program to Reduce Cardiovascular Disease Burden: Experience Implementing in the Americas and Opportunities in Canada43
Usefulness of Machine Learning-Based Detection and Classification of Cardiac Arrhythmias With 12-Lead Electrocardiograms41
Effectiveness of Mobile Health Technology Interventions for Patients With Heart Failure: Systematic Review and Meta-analysis41
Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers40
Angiotensin-Converting Enzyme 2 as the Molecular Bridge Between Epidemiologic and Clinical Features of COVID-1940
0.045091867446899